课题基金 / 基金详情

Assessing the impact of differing pharmacy tobacco retail displays on smokers awareness, perceptions, and intentions to quit

Assessing the impact of differing pharmacy tobacco retail displays on smokers awareness, perceptions, and intentions to quit
评估不同药房烟草零售展示对吸烟者意识、看法和戒烟意图的影响
批准号:
9280903
负责人:
Maansi Bansal-Travers
金额:
$18.93万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-01 至 2020-05-31

项目摘要

项目成果

Maansi Bansal-Travers的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Tobacco point-of-sale (PoS) displays and promotions have come to constitute the majority of tobacco industry advertising and marketing expenditures in the U.S. In 2012, the tobacco industry spent $9.6 billion on cigarette and smokeless tobacco marketing in the U.S., 84% of which was spent on marketing in the retail environment, and 94% of that spent on strategies specifically designed to reduce cigarette prices through price-related discounts. PoS exposures are found to increase youth smoking initiation, cue unplanned purchases, increase craving and relapse, and influence social norms about smoking, perceived access to cigarettes, brand switching, and support for stronger tobacco control policies. However, very little research has been done to determine the impact of smoking cessation messages at the PoS and how these messages may influence intention to quit and quitting behavior. In the U.S., pharmacists and pharmacies play a significant role in health care, working not only to provide medication, but often counseling individuals and their families on the use of those medications. The sale of tobacco in pharmacies, a product that when used as intended is associated with more than 480,000 deaths per year in the U.S., is inconsistent with this role. While the Family Smoking Prevention and Tobacco Control Act of 2009 does not allow the FDA to ban sales of tobacco in a specific type of retail outlet, states and local jurisdictions are abl to self-regulate (e.g., San Francisco, Massachusetts have passed laws banning the sales of tobacco in pharmacies). After the nation's largest pharmacy chain, CVS, ceased selling tobacco in September 2014, it converted the available display behind the cash registers into a marketing vehicle for their "Let's Quit Together" retail health clinic. At Walgreens (ranked #2) the principa display area remains saturated with tobacco products, with cessation aids relegated to the far side of the display wall, and no cessation message of any kind. At Rite Aid (ranked #3) a branded campaign "Quit for you" appears directly above the traditional array of tobacco products. These three very different approaches have not only changed the point-of-sale displays for tobacco products, but also the point-of-sale messages for smoking cessation. The goal of this timely project is to take advantage of an on-going natural experiment in the three largest US pharmacy chains to better understand consumer perceptions of differences in point-of-sale advertising for using and quitting tobacco, particularly how it is received, understood, an acted on by young adult cigarette smokers. This study will involve a field experiment in Buffalo, NY, with 186 current daily young adult (ages 18-34) smokers randomized to visit one of the three national chain pharmacies to complete a 5- minute purchase task. While completing the task, they will wear mobile eye-tracking equipment to measure attention to the PoS displays for tobacco/cessation messaging. The primary outcomes are the proportion of time spent looking at the PoS display and intention to quit. ). This study will be among the first to quantitatively asses what participants attend to when exposed to pro-tobacco and pro-cessation cues in a real world setting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research Project 4: Evaluating effects of packaging and market availability of flavored tobacco products on consumer perception and behavior
  • 批准号:
    10248510
  • 项目类别:
  • 资助金额:
    $33.08万
  • 财政年份:
    2018
  • 负责人:
    Maansi Bansal-Travers
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: